Financial Ratios Monstarlab Inc.

Stocks

5255

JP3928200009

IT Services & Consulting

Market Closed - Japan Exchange Other stock markets 04:30:00 10/08/26 pm AEST			5-day change	1st Jan Change
100.00 ^JPY	-1.96%		+9.89%	-40.48%

15/05	Monstarlab Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05/01	Monster Labor Board OKs Investment in Singapore-Based Fund	MT

dbb.ApFVPZq8TgDeQpbxLNkQBJEsIcDDfioiFBs5zIcnfsA.WOM5cbfpK3m3FvyfVZdkd6ZvYPGINGRmLElOpfNLLaE2y2B0zvYbV5w2rg

Published financial data: MONSTARLAB INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	9.35B	14.27B	13.35B	10B	7.8B
Total Revenues	9.35B	14.27B	13.35B	10B	7.8B
Cost of Goods Sold, Total	6.42B	9.33B	10.01B	8.58B	4.65B
Gross Profit	2.93B	4.94B	3.34B	1.42B	3.15B
Selling General & Admin Expenses, Total	4.24B	5.63B	6.13B	5.1B	2.53B
Provision for Bad Debts	-	-	62M	2.12B	85M
Other Operating Expenses	1.91B	-294M	139M	-449M	-64M
Other Operating Expenses, Total	6.15B	5.33B	6.34B	6.77B	2.55B
Operating Income	-3.22B	-389M	-3B	-5.35B	596M
Interest Expense, Total	-75M	-130M	-92M	-161M	-141M
Interest And Investment Income	208M	72M	3M	50M	2M
Net Interest Expenses	133M	-58M	-89M	-111M	-139M
Income (Loss) On Equity Invest.	-	-	-	-37M	-61M
Currency Exchange Gains (Loss)	-	-	-8M	573M	69M
Other Non Operating Income (Expenses)	1M	1M	14M	0	7M
EBT, Excl. Unusual Items	-3.09B	-446M	-3.08B	-4.92B	472M
Gain (Loss) On Sale Of Investments	-	-	938M	-684M	-719M
Gain (Loss) On Sale Of Assets	-	-	-2M	-	-
Asset Writedown	-	-	-15M	-4.24B	-72M
EBT, Incl. Unusual Items	-3.09B	-446M	-2.16B	-9.84B	-319M
Income Tax Expense	-1M	276M	163M	133M	39M
Earnings From Continuing Operations	-3.09B	-722M	-2.32B	-9.98B	-358M
Net Income to Company	-3.09B	-722M	-2.32B	-9.98B	-358M
Minority Interest	35M	48M	-35M	31M	21M
Net Income - (IS)	-3.05B	-674M	-2.36B	-9.95B	-337M
Preferred Dividend and Other Adjustments	-	-	-	-	86.92M
Net Income to Common Incl Extra Items	-3.05B	-674M	-2.36B	-9.95B	-424M
Net Income to Common Excl. Extra Items	-3.05B	-674M	-2.36B	-9.95B	-424M
Per Share Items
Net EPS - Basic	-113.17	-24.48	-70.06	-285.08	-7.48
Basic EPS - Continuing Operations	-113.17	-24.48	-70.06	-285.08	-7.48
Basic Weighted Average Shares Outstanding	26.98M	27.53M	33.61M	34.89M	56.69M
Net EPS - Diluted	-113.17	-24.51	-70.07	-285.1	-7.48
Diluted EPS - Continuing Operations	-113.17	-24.51	-70.07	-285.1	-7.48
Diluted Weighted Average Shares Outstanding	26.98M	27.53M	33.61M	34.89M	56.69M
Normalized Basic EPS	-70.27	-8.38	-58.27	-87.26	5.57
Normalized Diluted EPS	-70.27	-8.38	-58.27	-87.26	5.57
Supplemental Items
EBITDA	-	-	-2.56B	-5.01B	742M
EBITA	-3.22B	-389M	-3B	-5.35B	596M
EBIT	-3.22B	-389M	-3B	-5.35B	596M
Effective Tax Rate - (Ratio)	0.03	-61.88	-7.56	-1.35	-12.23
Normalized Net Income	-1.9B	-231M	-1.96B	-3.04B	316M
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	181M	172M	129M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	4.24B	2.72B	1.78B	1.55B	3.96B
Total Cash And Short Term Investments	4.24B	2.72B	1.78B	1.55B	3.96B
Accounts Receivable, Total	1.93B	3.07B	2.6B	733M	964M
Total Receivables	1.93B	3.07B	2.6B	733M	964M
Inventory	4M	-	60M	4M	-
Other Current Assets, Total	1.03B	2.02B	1.39B	436M	747M
Total Current Assets	7.2B	7.82B	5.84B	2.72B	5.67B
Net Property Plant And Equipment	331M	653M	615M	227M	143M
Long-term Investments	400M	522M	3.34B	3.58B	2.52B
Goodwill	1.03B	3.24B	3.96B	699M	699M
Other Intangibles, Total	933M	579M	651M	276M	181M
Deferred Tax Assets Long-Term	9M	109M	49M	80M	-
Other Long-Term Assets, Total	4M	4M	1M	1M	2M
Total Assets	9.91B	12.92B	14.46B	7.59B	9.21B
Liabilities
Accounts Payable, Total	1.46B	1.33B	1.13B	694M	643M
Short-term Borrowings	793M	1.92B	3.73B	2.57B	200M
Current Portion of Long-Term Debt	-	-	1B	799M	-
Current Portion of Leases	248M	312M	294M	122M	124M
Current Income Taxes Payable	58M	346M	181M	69M	44M
Other Current Liabilities	1.16B	1.57B	1.59B	1.45B	1.42B
Total Current Liabilities	3.73B	5.48B	7.93B	5.71B	2.43B
Long-Term Debt	1.77B	1.92B	1.49B	5.81B	5.75B
Long-Term Leases	811M	712M	549M	265M	54M
Deferred Tax Liability Non Current	191M	205M	108M	289M	193M
Other Non Current Liabilities	100M	506M	673M	293M	131M
Total Liabilities	6.6B	8.83B	10.76B	12.36B	8.55B
Common Stock, Total	392M	1.06B	1.92B	2.18B	1.15B
Additional Paid In Capital	8.8B	9.71B	10.5B	10.9B	1.58B
Retained Earnings	-5.53B	-6.2B	-8.56B	-18.5B	-2.72B
Comprehensive Income and Other	84M	14M	-152M	696M	691M
Total Common Equity	3.75B	4.58B	3.71B	-4.74B	700M
Minority Interest	-441M	-491M	-5M	-38M	-43M
Total Equity	3.31B	4.09B	3.71B	-4.78B	657M
Total Liabilities And Equity	9.91B	12.92B	14.46B	7.59B	9.21B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	29.85M	31.7M	34.33M	39.18M	64.66M
ECS Total Common Shares Outstanding	29.85M	31.7M	34.33M	39.18M	64.66M
Book Value / Share	125.7	144.6	108.11	-120.94	10.83
Tangible Book Value	1.79B	769M	-904M	-5.71B	-180M
Tangible Book Value Per Share	60.03	24.26	-26.33	-145.83	-2.78
Total Debt	3.62B	4.87B	7.08B	9.57B	6.12B
Net Debt	-620M	2.15B	5.29B	8.02B	2.17B
Minority Interest, Total (Incl. Fin. Div)	-441M	-491M	-5M	-38M	-43M
Equity Method Investments, Total	-	-	-	67M	-
Full Time Employees	1.35K	1.43K	1.4K	950	847
Part Time Employees	-	57	23	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	55M	950M	896M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-	-	-2.16B	-9.84B	-319M
Depreciation & Amortization - CF	-	-	436M	336M	146M
Depreciation & Amortization, Total	-	-	436M	336M	146M
(Gain) Loss From Sale Of Asset	-	-	15M	4.32B	77M
(Gain) Loss on Sale of Investments - (CF)	-	-	-938M	684M	-
Other Operating Activities, Total	-	-	-324M	-101M	-14M
Change In Accounts Receivable	-	-	532M	1.42B	-347M
Change In Inventories	-	-	-45M	55M	4M
Change In Accounts Payable	-	-	-397M	28M	38M
Change in Other Net Operating Assets	-	-	-641M	20M	268M
Cash from Operations	-	-	-3.52B	-3.09B	-147M
Capital Expenditure	-	-	-121M	-44M	-17M
Cash Acquisitions	-	-	-134M	-	-
Divestitures	-	-	-183M	-141M	91M
Sale (Purchase) of Intangible assets	-	-	-340M	-134M	-37M
Investment in Marketable and Equity Securities, Total	-	-	-429M	-	-
Other Investing Activities, Total	-	-	-31M	-74M	-66M
Cash from Investing	-	-	-1.24B	-393M	-29M
Short Term Debt Issued, Total	-	-	2.57B	3.71B	-
Long-Term Debt Issued, Total	-	-	680M	500M	-
Total Debt Issued	-	-	3.25B	4.21B	-
Short Term Debt Repaid, Total	-	-	-	-	-2.63B
Long-Term Debt Repaid, Total	-	-	-872M	-1.25B	-666M
Total Debt Repaid	-	-	-872M	-1.25B	-3.3B
Issuance of Common Stock	-	-	1.71B	14M	-
Other Financing Activities, Total	-	-	-370M	217M	5.87B
Cash from Financing	-	-	3.72B	3.19B	2.57B
Foreign Exchange Rate Adjustments	-	-	91M	60M	13M
Miscellaneous Cash Flow Adjustments	-	-	-1M	-	-1M
Net Change in Cash	-	-	-941M	-232M	2.41B
Supplemental Items
Cash Interest Paid	-	-	59M	157M	71M
Cash Income Tax Paid (Refund)	-	-	355M	108M	94M
Levered Free Cash Flow	-	-	-1.26B	-1.09B	-275M
Unlevered Free Cash Flow	-	-	-1.2B	-985M	-186M
Change In Net Working Capital	342M	1.57B	-695M	-2.2B	651M
Net Debt Issued / Repaid	-	-	2.38B	2.96B	-3.3B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-20.57	-2.13	-13.67	-30.31	4.43
Return on Total Capital	-28.37	-3.06	-18.96	-42.92	6.44
Return On Equity %	-95.37	-19.5	-59.49	1.87K	17.38
Return on Common Equity	-88.33	-16.17	-56.78	1.94K	21
Margin Analysis
Gross Profit Margin %	31.33	34.65	25.03	14.25	40.4
SG&A Margin	45.42	39.43	45.96	50.95	32.48
EBITDA Margin %	-	-	-19.17	-50.08	9.52
EBITA Margin %	-34.49	-2.73	-22.44	-53.44	7.65
EBIT Margin %	-34.49	-2.73	-22.44	-53.44	7.65
Income From Continuing Operations Margin %	-33.04	-5.06	-17.38	-99.75	-4.59
Net Income Margin %	-32.67	-4.72	-17.65	-99.44	-4.32
Net Avail. For Common Margin %	-32.67	-4.72	-17.65	-99.44	-5.44
Normalized Net Income Margin	-20.28	-1.62	-14.68	-30.44	4.05
Levered Free Cash Flow Margin	-	-	-9.44	-10.86	-3.52
Unlevered Free Cash Flow Margin	-	-	-9.01	-9.85	-2.39
Asset Turnover
Asset Turnover	0.95	1.25	0.97	0.91	0.93
Fixed Assets Turnover	18.94	29	21.05	23.76	42.14
Receivables Turnover (Average Receivables)	5.63	5.71	4.71	6	9.19
Inventory Turnover (Average Inventory)	2.57K	-	-	268.06	-
Short Term Liquidity
Current Ratio	1.93	1.43	0.74	0.48	2.33
Quick Ratio	1.65	1.06	0.55	0.4	2.03
Operating Cash Flow to Current Liabilities	-	-	-0.44	-0.54	-0.06
Days Sales Outstanding (Average Receivables)	64.89	63.93	77.58	60.98	39.73
Days Outstanding Inventory (Average Inventory)	0.14	-	-	1.37	-
Average Days Payable Outstanding	65.94	-	-	39.21	-
Cash Conversion Cycle (Average Days)	-0.91	-	-	23.13	-
Long Term Solvency
Total Debt/Equity	109.36	119.03	190.91	-200.29	932.27
Total Debt / Total Capital	52.24	54.34	65.62	199.71	90.31
LT Debt/Equity	77.92	64.4	55.1	-127.16	882.95
Long-Term Debt / Total Capital	37.22	29.4	18.94	126.78	85.54
Total Liabilities / Total Assets	66.59	68.32	74.37	162.93	92.87
EBIT / Interest Expense	-42.97	-2.99	-32.55	-33.2	4.23
EBITDA / Interest Expense	-	-	-27.82	-31.12	5.26
(EBITDA - Capex) / Interest Expense	-	-	-29.13	-31.39	5.14
Total Debt / EBITDA	-	-	-2.76	-1.91	8.25
Net Debt / EBITDA	-	-	-2.07	-1.6	2.92
Total Debt / (EBITDA - Capex)	-	-	-2.64	-1.89	8.45
Net Debt / (EBITDA - Capex)	-	-	-1.97	-1.59	2.99
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	25.97	52.69	-6.48	-25.05	-22.07
Gross Profit, 1 Yr. Growth %	36.38	68.85	-32.44	-57.34	120.98
EBITDA, 1 Yr. Growth %	-	-	-	95.78	-114.81
EBITA, 1 Yr. Growth %	114.58	-87.93	669.92	78.5	-111.15
EBIT, 1 Yr. Growth %	114.58	-87.93	669.92	78.5	-111.15
Earnings From Cont. Operations, 1 Yr. Growth %	109.78	-76.62	221.33	330.09	-96.41
Net Income, 1 Yr. Growth %	139.64	-77.92	249.41	322.38	-96.61
Normalized Net Income, 1 Yr. Growth %	146.34	-87.83	748.86	55.44	-110.38
Diluted EPS Before Extra, 1 Yr. Growth %	102.55	-78.34	185.91	306.88	-97.38
Accounts Receivable, 1 Yr. Growth %	37.87	59.55	-15.39	-71.81	31.51
Inventory, 1 Yr. Growth %	300	-	-	-93.33	-
Net Property, Plant and Equip., 1 Yr. Growth %	-49.54	97.28	-5.82	-63.09	-37
Total Assets, 1 Yr. Growth %	2.43	30.4	11.92	-47.52	21.36
Tangible Book Value, 1 Yr. Growth %	330.77	-57.09	-217.56	531.97	-96.85
Common Equity, 1 Yr. Growth %	18.7	22.17	-19.04	-227.67	-114.77
Cash From Operations, 1 Yr. Growth %	-	-	-	-12.28	-95.24
Capital Expenditures, 1 Yr. Growth %	-	-	-	-63.64	-61.36
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-	-13.78	-74.71
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-	-18.02	-81.07
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	38.69	19.5	-16.28	-23.58
Gross Profit, 2 Yr. CAGR %	-	51.75	6.8	-46.31	-2.9
EBITDA, 2 Yr. CAGR %	-	-	-	-	-46.15
EBITA, 2 Yr. CAGR %	-	-49.11	-3.6	270.71	-55.39
EBIT, 2 Yr. CAGR %	-	-49.11	-3.6	270.71	-55.39
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-29.97	-13.32	271.75	-60.72
Net Income, 2 Yr. CAGR %	-	-27.26	-12.17	284.16	-62.17
Normalized Net Income, 2 Yr. CAGR %	-	-45.24	1.65	263.24	-59.83
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-33.77	-21.31	241.07	-67.33
Accounts Receivable, 2 Yr. CAGR %	-	48.31	16.19	-51.16	-39.11
Inventory, 2 Yr. CAGR %	-	-	287.3	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-0.23	36.31	-41.04	-51.78
Total Assets, 2 Yr. CAGR %	-	15.57	20.8	-23.36	-20.19
Tangible Book Value, 2 Yr. CAGR %	-	35.96	-28.97	172.56	-55.38
Common Equity, 2 Yr. CAGR %	-	20.42	-0.55	1.67	-56.57
Cash From Operations, 2 Yr. CAGR %	-	-	-	-	-79.56
Capital Expenditures, 2 Yr. CAGR %	-	-	-	-	-62.52
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-	-53.3
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-	-60.61
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	21.62	2.29	-18.25
Gross Profit, 3 Yr. CAGR %	-	-	15.87	-21.34	-13.96
EBITA, 3 Yr. CAGR %	-	-	25.87	18.37	15.28
EBIT, 3 Yr. CAGR %	-	-	25.87	18.37	15.28
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	16.38	47.84	-20.85
Net Income, 3 Yr. CAGR %	-	-	22.73	48.25	-20.63
Normalized Net Income, 3 Yr. CAGR %	-	-	36.54	17.11	11.05
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	7.84	36.07	-32.67
Accounts Receivable, 3 Yr. CAGR %	-	-	23.01	-27.53	-32.05
Inventory, 3 Yr. CAGR %	-	-	291.49	0	-
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-2.13	-11.81	-39.72
Total Assets, 3 Yr. CAGR %	-	-	14.34	-8.51	-10.67
Tangible Book Value, 3 Yr. CAGR %	-	-	29.53	47.18	-38.37
Common Equity, 3 Yr. CAGR %	-	-	5.49	8.09	-46.55
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	0.99
Gross Profit, 5 Yr. CAGR %	-	-	-	-	7.96
EBITA, 5 Yr. CAGR %	-	-	-	-	-16.88
EBIT, 5 Yr. CAGR %	-	-	-	-	-16.88
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	-24.63
Net Income, 5 Yr. CAGR %	-	-	-	-	-23.35
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	-16.31
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	-33.11
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	-7.15
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	-26.26
Total Assets, 5 Yr. CAGR %	-	-	-	-	-0.98
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	-15.43
Common Equity, 5 Yr. CAGR %	-	-	-	-	-26.03